Department of Quantum Medical Technology, Kanazawa University School of Medicine, 5-11-80 Kodatsuno, Kanazawa 920-0942, Japan.
Jpn J Radiol. 2013 Jan;31(1):9-15. doi: 10.1007/s11604-012-0136-x. Epub 2012 Oct 3.
To reveal the incidence and degree of intrahepatic periportal high intensity (PHI) on hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI (EOB-MRI) in patients with or without various hepatobiliary diseases.
Patients with normal liver (N = 256) and those with hepatic disorder (N = 857) who underwent EOB-MRI were the subjects in this study. Incidence of PHI was evaluated among the patients with normal liver and those with hepatic disorder. Degree of PHI was categorized into four grades and compared among the various hepatic diseases. Enhancement ratios (ER) of the PHI area, background liver with PHI, and background liver in control cases without PHI were evaluated.
PHI was observed in 2.7 % of the patients with hepatic disorder. No PHI was observed in the patients with normal liver. The incidence rates of PHI among various hepatobiliary diseases were as follows; liver cirrhosis 3.1 %, chronic hepatitis 1.0 %, primary biliary cirrhosis 12.5 %, idiopathic portal hypertension 33.3 %. The ER of the PHI area and background liver were 3.92 and 2.48 (p = 0.0002). There were no significant differences between the ER of the PHI area and the ER of background liver in the noncirrhotic control without PHI.
In 2.7 % of the patients with a hepatic disorder, the periportal area was saved from decrease of EOB uptake and it showed PHI.
揭示 Gd-EOB-DTPA 增强 MRI(EOB-MRI)肝胆期图像上肝内门脉周围高信号(PHI)的发生率和程度,包括有无各种肝胆疾病的患者。
本研究纳入了 256 例正常肝脏患者和 857 例肝脏疾病患者。评估正常肝脏患者和肝脏疾病患者中 PHI 的发生率。将 PHI 程度分为四级,并比较各种肝脏疾病之间的差异。评估 PHI 区域、有 PHI 的背景肝和无 PHI 的对照组背景肝的增强比(ER)。
肝脏疾病患者中观察到 2.7%的 PHI。正常肝脏患者中未观察到 PHI。各种肝胆疾病中 PHI 的发生率如下:肝硬化 3.1%,慢性肝炎 1.0%,原发性胆汁性肝硬化 12.5%,特发性门静脉高压症 33.3%。PHI 区域和背景肝的 ER 分别为 3.92 和 2.48(p=0.0002)。在无 PHI 的非肝硬化对照组中,PHI 区域的 ER 与背景肝的 ER 之间无显著差异。
在 2.7%的肝脏疾病患者中,门脉周围区域从 EOB 摄取减少中得到保护,并显示 PHI。